1 December 2024 false No description of principal activity Taxfiler 2024.6 14480699 business:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 14480699 2024-11-30 14480699 2024-12-01 2025-11-30 14480699 business:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 14480699 business:FilletedAccounts 2024-12-01 2025-11-30 14480699 2025-11-30 14480699 business:Director1 2024-12-01 2025-11-30 14480699 business:RegisteredOffice 2024-12-01 2025-11-30 14480699 2024-11-30 14480699 core:WithinOneYear 2025-11-30 14480699 core:WithinOneYear 2024-11-30 14480699 core:ShareCapital core:PreviouslyStatedAmount 2025-11-30 14480699 core:ShareCapital core:PreviouslyStatedAmount 2024-11-30 14480699 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-11-30 14480699 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-11-30 14480699 core:PreviouslyStatedAmount 2025-11-30 14480699 core:PreviouslyStatedAmount 2024-11-30 14480699 business:SmallEntities 2024-12-01 2025-11-30 14480699 countries:EnglandWales 2024-12-01 2025-11-30 14480699 core:PlantMachinery 2024-11-30 14480699 core:PlantMachinery 2024-12-01 2025-11-30 14480699 core:PlantMachinery 2025-11-30 14480699 2023-12-01 2024-11-30 iso4217:GBP xbrli:pure
Company Registration No. 14480699 (England and Wales)
Sparrowhawk Pharma Limited Unaudited accounts for the year ended 30 November 2025
Sparrowhawk Pharma Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Sparrowhawk Pharma Limited Company Information for the year ended 30 November 2025
Director
Ummer Ayyaz
Company Number
14480699 (England and Wales)
Registered Office
14 Altar Drive Bradford West Yorkshire BD9 5QD England
- 3 -
Sparrowhawk Pharma Limited Statement of financial position as at 30 November 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
2,760
2,536
Current assets
Cash at bank and in hand
21,508
22,897
Creditors: amounts falling due within one year
5
(5,547)
(11,251)
Net current assets
15,961
11,646
Net assets
18,721
14,182
Capital and reserves
Called up share capital
100
100
Profit and loss account
18,621
14,082
Shareholders' funds
18,721
14,182
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 8 May 2026 and were signed on its behalf by
Ummer Ayyaz Director Company Registration No. 14480699
- 4 -
Sparrowhawk Pharma Limited Notes to the Accounts for the year ended 30 November 2025
1
Statutory information
Sparrowhawk Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 14480699. The registered office is 14 Altar Drive, Bradford, West Yorkshire, BD9 5QD, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
4
Tangible fixed assets
Plant & machinery
£
Cost or valuation
At cost
At 1 December 2024
4,226
Additions
1,336
At 30 November 2025
5,562
Depreciation
At 1 December 2024
1,690
Charge for the year
1,112
At 30 November 2025
2,802
Net book value
At 30 November 2025
2,760
At 30 November 2024
2,536
5
Creditors: amounts falling due within one year
2025
2024
£
£
Taxes and social security
4,660
8,004
Loans from directors
137
-
Accruals
750
3,247
5,547
11,251
- 5 -
Sparrowhawk Pharma Limited Notes to the Accounts for the year ended 30 November 2025
6
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 6 -